Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Gene diagnosis marker for dengue fever and dengue hemorrhagic fever

A technology for dengue hemorrhagic fever and dengue fever, applied in biological testing, biomaterial analysis, biochemical equipment and methods, etc., can solve problems such as difficult diagnosis and complicated clinical manifestations of dengue virus infection, and achieve accurate results, detection sensitivity and good specific effect

Inactive Publication Date: 2018-09-28
QINGDAO MEDINTELL BIOMEDICAL CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] The clinical manifestations of dengue virus infection are very complex, and most of the symptoms are indistinguishable from diseases such as malaria, typhoid fever, and chikungunya fever. It is difficult to make a clear diagnosis based solely on the epidemiological data and clinical manifestations of patients, so laboratory tests are required for further diagnosis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Gene diagnosis marker for dengue fever and dengue hemorrhagic fever
  • Gene diagnosis marker for dengue fever and dengue hemorrhagic fever
  • Gene diagnosis marker for dengue fever and dengue hemorrhagic fever

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] Example 1 Screening of genes differentially expressed in patients with dengue fever and / or dengue hemorrhagic fever and normal people

[0046] 1. Research object:

[0047] Disease group: Collect 5 patients with dengue fever, 5 patients with dengue hemorrhagic fever, all patients according to "WHO / TDR.Dengue-Guidelines for diagnosis, Treatment, prevention and control.2009; http: / / www.who.int / tdr / publications / training-guideline-publications / dengue-diagnosis-treatment / en / index.html.Date of Access: 12 / 05 / 2015.2009" for diagnosis.

[0048] Normal group: 4 healthy volunteers were selected.

[0049] There was no significant difference in age and gender between the two groups (P>0.10), which were comparable.

[0050] All research subjects were informed about this study and signed the informed consent.

[0051] 2. Extraction of total RNA in blood

[0052] (1) Fresh whole blood, erythrocyte lysate (1:1), mix by inverting several times, let stand for 5 minutes. 10000g, 4°C, ...

Embodiment 2

[0069]Example 2 Reverse transcription PCR experiment verifies the genes differentially expressed in patients with dengue fever and / or dengue hemorrhagic fever and normal people

[0070] The differentially expressed gene-CACNB1 gene screened out in Example 1 was selected for large sample verification.

[0071] 1. Research object:

[0072] Disease group: Collect 30 patients with dengue fever, 25 patients with dengue hemorrhagic fever, all patients according to "WHO / TDR.Dengue-Guidelines for diagnosis, Treatment, prevention and control.2009; http: / / www.who.int / tdr / publications / training-guideline-publications / dengue-diagnosis-treatment / en / index.html.Date of Access: 12 / 05 / 2015.2009" for diagnosis.

[0073] Normal group: select 30 cases of healthy volunteers.

[0074] There was no significant difference in age and gender between the two groups (P>0.10), which were comparable.

[0075] All research subjects were informed about this study and signed the informed consent.

[0076]...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a diagnosis tool for dengue fever and dengue hemorrhagic fever. The diagnosis tool fulfills the aim of diagnosis by detecting a CACNB1 gene in blood and an expression product thereof. According to the invention, researches prove that compared to normal people, mRNA expression levels of the CACNB1 gene in blood of patients suffering from the dengue fever and the dengue hemorrhagic fever are obviously reduced. According to correlation between the CACNB1 gene and the dengue fever and the dengue hemorrhagic fever, a kit for diagnosing the dengue fever and the dengue hemorrhagic fever can be prepared; the kit can be widely clinically applied.

Description

technical field [0001] The invention belongs to the field of epidemiological diagnosis and prevention, and relates to a genetic diagnostic marker for dengue fever and dengue hemorrhagic fever. Background technique [0002] Since the Antonine plague (Shrap R, Lotka A J.A Problem in AgeDistribution[J].Philosophical Magazine, 1911,21:35-438) in the 2nd century AD, infectious diseases have been endangering human health and brought huge impacts on social stability. Impact. In recent years, the incidence of dengue infectious disease has increased rapidly and has become a world public health problem, and it is recorded as a disease in Appendix II of the newly revised International Health Regulations (2005). Dengue fever is an acute infectious disease caused by dengue virus and transmitted by Aedes mosquitoes. At first, people named it joint fever and fracture fever according to its symptoms (Monath, T.P. Dengue: The risk to developed and developing countries: Proc. Nat. Acad. Sci...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/70C12Q1/686C12Q1/6851C12Q1/6841C12Q1/6869G01N33/68G01N33/569
CPCC12Q1/6841C12Q1/6851C12Q1/686C12Q1/6869C12Q1/701G01N33/56983G01N33/68G01N2333/185Y02A50/30
Inventor 贾宏毅向常娟
Owner QINGDAO MEDINTELL BIOMEDICAL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com